Option chain shows key data for Hansa Biopharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hansa Biopharma.

Hansa Biopharma (OTC:HNSBF) Stock, Option Chain

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABCP

AEMD

AFTM

AGFAF

ALTAF

AMRK

ANDR

APAFF

ARXXL

ASPCF

BLOZF

BOSQF

BOTH

BSRC

BTCY

BTSC

BVLDF

BVNNF

CADMF

CBLRF

CLIRF

CLOW

CMGHF

CNBX

CNONF

CONN

COTE

CPNFF

CRNT

CTRM

CTVIF

CWBHF

DAUGF

DOGZ

ELGX

ENDV

ENRT

EVIO

FAMI

FCGD

GALOF

GCFB

GFTX

GGBXF

GLBS

GOSS

GRPBF

GTEC

HEMP

HHPHF

HNSBF

IGRW

INAP

IQST

JILL

JUTOY

KGET

KOPN

LATF

LIXT

LQDA

LTMCF

MDCN

MMJJF

MOGLF

NMHLY

NMKEF

NSUPF

NVSGF

NXTTF

NZRIF

OTEL

OTOW

OZSC

PAOTF

PHUN

PIXY

PMTS

PRRE

PSIX

PTOTF

QRTEA

QRTEB

RETC

RGLSF

RNSFF

SCNNF

SEED

SHLO

SNAVF

SNIRF

SXTC

TCHH

TISUQ

TLRY

Stocks That Hit 52-Week Lows On Tuesday

ACWRF

ADMP

ALLEGIANT GOLD LTD by Allegiant Gold Ltd.

AUXXF

AVPMF

BBAR

BKTPF

BKYI

BTKRF

CEPU

CGTFF

CMCLF

CNPOF

CREX

DKGH

DNJR

DVCR

EGRNY

EMESQ

EOPT

FISOF

GGAL

GLDFF

GTXO

GYNAF

HCCC

HYSR

ITKG

IVITF

JAPAF

LDSYF

LGF-B

LMNR

MFCSF

MGAFF

MJARF

MKTAY

MMDM

MTZPY

NSANF

NSANY

NSPDF

NXES

OLLI

OSBC

OVCHY

PAHC

PDCO

PTNUF

RLLVF

SCOO

SGBX

SPECTRUM GLOBAL SOLUTIONS by Spectrum Global Solutions, Inc.

SGSI

SNNVF

SRHIF

SWDBY

TATT

Telecom Argentina Stet - France Telecom S.A.

THDDY

TTSRF

TWMC

VSBGF

WSTL

XREG

SPPDF

SENS

INDXF

EXSPF

RZREF

MCUIF

QZMRF

Stocks That Hit 52-Week Lows On Thursday

Hansa Biopharma AB

Additional Transaction Details
The following information is being provided in accordance with the disclosure requirements of the AIM rules. Under the terms of the agreement, Maxcyte paid a total initial consideration of $4.5 million at closing in cash for the entire issued share capital of SeQure DX on a cash free, debt free basis&nbsp;using Maxcyte's existing cash resources. An additional amount, that will not exceed $2.5 million, may be paid in contingent consideration if the company exceeds certain revenue targets.&nbsp;In 2024 (based on available unaudited results from January 1 through November 30), SeQure DX incurred revenue of approximately $1.7 million and a loss of approximately $6.5 million and has net assets of $0.7 million as of closing.

MXCT

MaxCyte Buys SeQure Dx For $4.5M Plus Up To $2.5M Contingent, Expanding Cell Engineering Capabilities

<ul>
<li>The deal gives Molson Coors exclusive commercialization rights to Fever-Tree's U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc</li>
<li>Partnership designed to fuel Molson Coors' Premiumization and Beyond Beer strategies</li>
</ul>

Molson Coors Secures Exclusive U.S. Rights To Fever-Tree In Strategic Partnership And Equity Investment

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Neutral&#8221; zone on Wednesday.
U.S. stocks settled lower on Wednesday after the Federal Reserve left interest rates unchanged at its recent policy meeting.
NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell over 4% on Wednesday amid reports indicating Trump officials have discussed further curbing China sales.
General Dynamics Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) reported better-than-expected fourth-quarter fiscal 2024 results. Corning Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) posted better-than-expected fourth-quarter financial results and also issued first-quarter core EPS guidance with a midpoint above estimates.
On the economic data front, the U.S. trade deficit in goods increased to a record $122.11 billion in December versus a revised $103.5 billion gap in the prior month. U.S. wholesale inventories declined by 0.5% month-over-month to $898 billion in December following a revised 0.1% fall in the previous month and versus market estimates of a 0.2% gain.
Most sectors on the S&amp;P 500 closed on a negative note, with information technology, real estate, and healthcare stocks recording losses on Wednesday. However, consumer staples and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 137 points to 44,713.52 on Wednesday. The S&amp;P 500 fell 0.47% to 6,039.31, while the Nasdaq Composite fell 0.51% at 19,632.32 during Wednesday's session.
Investors are awaiting earnings results from Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), and Caterpillar Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 45.6, the index remained in the &#8220;Neutral&#8221; zone on Wednesday, versus a prior reading of 47.3.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43300989/jim-cramer-this-industrial-stock-is-absolutely-terrific-first-solar-is-very-inexpensive">Jim Cramer: This Industrial Stock Is &#8216;Absolutely Terrific&#8217;, First Solar Is &#8216;Very Inexpensive&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

AAPL

NVDA

Nasdaq Declines As Nvidia Edges Lower, Fed Leaves Interest Rates Unchanged: Fear & Greed Index In 'Neutral' Zone

Sound Financial Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFBC#NASDAQ">SFBC</a>) reported quarterly earnings of $0.74 per share. This is a 57.45 percent increase over earnings of $0.47 per share from the same period last year. The company reported $9.38 million in sales this quarter. This is a 8.65 percent increase over sales of $8.63 million the same period last year.

SFBC

Reported Wednesday, Sound Financial Bancorp Q4 EPS $0.74 Up From $0.47 YoY, Sales $9.38M Up From $8.63M YoY

Reported Earlier, Carlyle Backs Entertainment 360 With Strategic Investment To Drive Industry Growth

Settlement expected to result in approximately $50 million less revenue annually and a reduction in electric customer bills by about $1 a month for most customers while also continuing to deliver support for significant local economic growth and upgrades across Greater Houston area
Combination of rate case revenue reduction and other financial commitments, including some 2024 foregone storm recovery costs, would roughly equal the same amount that has been billed to CenterPoint customers for the temporary generation costs since 2021
Company would make no revenue or profit off of the temporary emergency generator proposal to help ERCOT and State of Texas which would have otherwise been paid by all customers across the state including CenterPoint customers

Reported Earlier, CenterPoint Energy Reaches Settlement To Lower Houston Electric Bills, Cutting Revenue by $50M Annually

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to report quarterly earnings at $2.35 per share on revenue of $124.13 billion after the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Apple shares fell 0.1% to $239.26 in after-hours trading.</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reported weaker-than-expected fourth-quarter earnings and sales results. The company, meanwhile, said it expects its vehicle business to return to growth in 2025. Tesla also promised to launch new and "more affordable" models in the first half of 2025, in addition to other promises regarding the deployment of autonomous vehicles and licensing of the company's full self-driving (FSD) driver assistance software to rivals. Tesla shares gained 4.1% to $405.23 in the after-hours trading session.</li>
<li>Analysts are expecting United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) to post quarterly earnings at $2.53 per share on revenue of $25.42 billion. The company will release earnings before the markets open. UPS shares gained 2% to $136.40 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) reported better-than-expected fourth-quarter sales results. Meta reported fourth-quarter revenue of $48.39 billion, beating analyst estimates of $47.03 billion. The company reported fourth-quarter earnings of $8.02 per share, beating analyst estimates of $6.77 per share. Meta shares rose 2.3% to $692.01 in the after-hours trading session.</li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported its second-quarter GAAP earnings of $3.23 per share, beating the $3.11 consensus estimate. Quarterly revenue clocked in at $69.6 billion, beating the $68.78 billion analyst consensus estimate. Revenue in Microsoft's Intelligent Cloud segment was $25.5 billion and increased 19%. Microsoft's shares fell 4.6% to $421.80 in the after-hours trading session.</li>
</ul>
Check This Out:
<ul>
<li> <a href="https://www.benzinga.com/25/01/43300989/jim-cramer-this-industrial-stock-is-absolutely-terrific-first-solar-is-very-inexpensive">Jim Cramer: This Industrial Stock Is &#8216;Absolutely Terrific&#8217;, First Solar Is &#8216;Very Inexpensive&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Tesla, Apple And 3 Stocks To Watch Heading Into Thursday

Comments

Hansa Biopharma

Hansa Biopharma (HNSBF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga